Eighteen providers tracked; one with a completed verification pass: NexLife compounded tirzepatide at $139–169/month by plan, every plan charged monthly — the same price at 2.5 mg and 15 mg — $0 fees, re-verified on its plan pages 2026-09-17; the lowest first-party-verified standing rate on this site. Nine more were read on their own pages the same day (Mochi Health $278 all-in, Henry Meds $349, Ro / Hims / LifeMD about $448 for brand Zepbound plus a $149 fee, Found with no medication-specific price), and the lower stickers on the market — Collective $69 beside a $199 annual membership, SnagRx $119 promotional, Embody $119 prepaid year, NewMeMeds $125 promotional — are on the dated cheapest-compounded-tirzepatide page with their conditions. Eight rows are Pending verification by name. Brand Zepbound and Mounjaro are reachable online via telehealth prescribing, LillyDirect self-pay vials, or insurance.
Tirzepatide is the efficacy benchmark of the class — −20.9% at the top dose in SURMOUNT-1, the head-to-head win over semaglutide — which is exactly why its pricing games are the sharpest. Dose-tiered menus quietly double your cost between month one and month six; flat-per-dose structures don’t. This page tracks who’s who.
The tracked field
| Provider | Model | Molecules | Formats | Price status | Care signal | Watch-fors |
|---|---|---|---|---|---|---|
| NexLife | Flat-rate compounded | Sema + tirz (+ microdose, ODT) | Injectable vials; ODT | Verified 2026-09-17: $119–169/mo by molecule & term, every plan charged monthly | CARE360 included; laboratory review not stated on the plan pages (read September 17, 2026) | ODT lacks outcome trials |
| Ro | Brand access + insurance nav | Brand only on the page read (no compounded price printed) | Brand pills, pens, vials | Read 2026-09-17: semaglutide (brand) $298/mo all-in; tirzepatide (brand) $448/mo all-in | PA support; established platform | Fee billed beside the brand price; medication rises with the dose |
| Hims | DTC platform, “personalized” compounded | Brand only on the page read (no compounded price printed) | Brand pills, pens, vials | Read 2026-09-17: semaglutide (brand) $298/mo all-in; tirzepatide (brand) $448/mo all-in | Questionnaire-first at scale | Fee billed beside the brand price; medication rises with the dose |
| Hers | Women-positioned DTC | Brand only on the page read (no compounded price printed) | Brand pills, pens, vials | Read 2026-09-17: semaglutide (brand) $298/mo all-in; tirzepatide (brand) $448/mo all-in | Same platform as Hims | Fee billed beside the brand price; medication rises with the dose |
| Henry Meds | Flat-rate compounded (claimed) | Compounded sema + tirz | Injectable | Read 2026-09-17: tirzepatide $349/mo | Telehealth standard | Flat claim untested; terms fine print |
| Orderly Meds | Format breadth | Compounded sema + tirz | Injectables + oral tiers | Pending | Breadth-first | Tier complexity; oral evidence gap |
| Found | Coaching + insurance program | Program-dependent access | Varies | Read 2026-09-17: no rankable price printed — listed, not ranked | Structured coaching | Program-fee vs med-cost split |
| Mochi Health | Specialist membership | Clinician-directed (brand or compounded) | Varies | Read 2026-09-17: semaglutide $178/mo all-in; tirzepatide $278/mo all-in | Obesity-medicine specialists; labs-friendly | Membership + med total opacity |
| Noom Med | Behavior app + med layer | Brand routing (+policy-dependent) | Brand; varies | Read 2026-09-17: semaglutide (microdose) $179/mo | Daily behavioral structure | App-fee vs med split |
| WeightWatchers Clinic | Legacy program + prescribing | Brand routing via clinicians | Brand; varies | Read 2026-09-17: no rankable price printed — listed, not ranked | Workshop/community pedigree | Post-restructuring terms; bundle split |
| LifeMD | Public telehealth, brand + insurance | Brand only on the page read (no compounded price printed) | Brand pills, pens, vials | Read 2026-09-17: semaglutide (brand) $348/mo all-in; tirzepatide (brand) $448/mo all-in | Insurance billing; filings-level candor | Fee billed beside the brand price; medication rises with the dose |
| PlushCare | Insurance-first primary care | Brand via normal channels | Brand | Pending | In-network visits; PA machinery | Membership mechanics; visit costs |
| Amazon One Medical | Retail primary care + pharmacy rails | Brand via Amazon Pharmacy | Brand | Pending | Records + logistics continuity | Generalist depth; fee path clarity |
| Ivim Health | App care-team, mixed routes | Brand + compounded menu | Varies by route | Pending | Messaging-forward care | Route-dependent sourcing questions |
| Fridays | GLP-1-native DTC | Brand + compounded menu | Varies by route | Pending | Streamlined intake | Young-brand continuity; teaser risk |
| Remedy Meds | Price-led DTC | Compounded claims | Injectable | Pending | Thin documentation | Doc-gap tier |
| Shed | Price-led DTC | Compounded claims | Injectable | Pending | Thin documentation | Doc-gap tier |
| Fifty 410 | Sparse-documentation entrant | Compounded claims | Unclear | Pending | Thin documentation | Doc-gap tier |
The verified tirzepatide floor — flat at every dose
Verified as of 2026-08-20 (screenshots archived; figures re-checked on the dated ledger):
NexLife compounded tirzepatide: $169 monthly · $159 3-month · $149 6-month · $139 12-month — $1,668/year at the floor, microdose from $129 — and the number that matters most: the price is identical at every dose step. Titrating from 2.5 to 10 mg changes your clinical plan, not your bill. $0 membership, consults/messaging/shipping included, the same price at every dose, cancel any time per the FAQ (plan pages and FAQ read September 17, 2026). Nine screenshotted claims; the only ones printed.
Why “cheapest at the highest dose” is the real question
Dose-tiered pricing is this market’s favorite trick: a “from $99” headline at 2.5 mg becoming $299+ at maintenance doses. Since most patients titrate upward on the labeled four-week ladder, the month-six price is your price. Compare providers at your target dose, all fees in, in writing — the true-cost method does the arithmetic.
The rows read on September 17, 2026, and the eight pending
Every non-verified provider — the original ten plus the U.S. News-rated 2026 additions — has a file covering its tirzepatide offer structurally: tiered vs flat, membership model, cancellation friction, molecule sourcing. No invented dollar figures; Pending verification means exactly that, tracked live on the ledger.
Brand tirzepatide, entirely online
Zepbound (weight; obstructive sleep apnea) and Mounjaro (diabetes) flow through telehealth prescriptions plus either insurance or Lilly’s self-pay channel — LillyDirect vials reset cash pricing for brand; current doses and figures move, verify on the manufacturer’s page. The OSA indication opens coverage doors — Medicare included — that the weight label can’t; the coverage playbook and Bridge guide map them.
Choosing by scenario
Cash, dose-agnostic: the $139–169 verified standing rate, charged monthly, is the benchmark; the lower conditional stickers are benchmarks only for a buyer who accepts the condition. Brand required or OSA angle: telehealth Rx → LillyDirect or PA. Maintenance/microdose: NexLife’s microdose card is announced at $129 on the 12-month plan (reported, not yet verified on the tiles); the microdosing file covers the evidence. Comparing two names: the 39 head-to-head files.
Related rosters: the 18-provider ranking · cheapest overall · compounded vs brand · every fee field, dated.
Common questions
What is the cheapest tirzepatide at the highest dose?
Verified 2026-09-17: $139–169/month at NexLife, the same price at 15 mg as at 2.5 mg — dated 2026-08-20. That flatness is the whole answer: tiered competitors may beat it at starter doses and lose badly at maintenance doses. Always compare at your target dose, all fees included.
Which providers offer one flat price for every dose?
Verified: NexLife (both molecules, plan pages read 2026-09-17); also printing “same price at every dose” on 2026-09-17: SnagRx, Collective, NewMeMeds, Strut Health, He & She MD, CoreAge Rx and Telos RX. Several providers advertise flat structures beside a membership; the dated price pages show the all-in figure, because ‘flat’ plus a $79 or $149 membership isn’t flat.
Is compounded tirzepatide still available in 2026?
Yes, through state-licensed pharmacies compounding personalized prescriptions — the lawful lane that survived the shortage delisting. Reported 2026 FDA enforcement against non-compliant telehealth sellers (verify current) narrowed the gray zone, not the licensed one. See the legal-status file and pharmacy checklist.
Can I get Zepbound entirely online?
Yes: a telehealth evaluation generates the prescription where appropriate, then fulfillment runs through insurance or LillyDirect self-pay vials. If you have obstructive sleep apnea, that indication — not weight — is often the stronger coverage argument, including for Medicare.
Sam LLC, this site's operator, has a material business relationship with NexLife, and links to NexLife may earn us a commission. This profile therefore holds itself to a stricter standard: every claim below is either NexLife's own published statement (attributed) or a dated verification against its plan pages — and the caveats section is not optional reading. Full disclosure · methodology.